Back to search

Switzerland· 69672001

Ryaltris 25 μg / 600 μg, Nasenspray, Suspension

A mometason, kombinationen product containing mometasoni furoas, olopatadinum, registered in Switzerland by NOBEL Pharma Schweiz AG and dispensed under Swissmedic category B. The same ATC class is registered in 10 of our 19 countries.

Cat B (Swissmedic)ATC R01AD59

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedRyaltris 25 μg / 600 μg, Nasenspray, …ATCR01AD59REGISTER NO.69672001PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Mometason, kombinationen is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AD59 (mometason, kombinationen), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 6 of them publish a price we can compare per daily dose

Mometason, kombinationen · ATC R01AD59

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
mometasoni furoas, olopatadinum
Manufacturer
NOBEL Pharma Schweiz AG
Country
Switzerland (CH)
ATC code
R01AD59
ATC class
Mometason, Kombinationen
Defined daily dose
0.2 mg, N
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mometason, kombinationen in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mometason, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Ryaltris
  • Belgium · Ryaltris
  • Czechia · Ryaltris
  • Germany · Ryaltris
  • Denmark · Ryaltris
  • Spain · Ryaltris
  • Finland · Ryaltris
  • France · Ryaltris
  • United Kingdom (Northern Ireland) · Ryaltris
  • Ireland · Ryaltris
  • Italy · Rineffix, Ryaltris
  • Lithuania · Ryaltris
  • Luxembourg · Ryaltris
  • Latvia · Ryaltris
  • Malta · Ryaltris
  • Netherlands · Ryaltris
  • Norway · Ryaltris
  • Poland · Ryaltris
  • Romania · Ryaltris
  • Sweden · Mometasone Furoate/Olopatadine Glenmark, Ryaltris
  • Slovakia · Ryaltris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aafd9bd5-891d-4745-8395-7d5383d1a635
GET /v1/drugs/aafd9bd5-891d-4745-8395-7d5383d1a635?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about mometason, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.